Clovis Oncology
CLVS
$0.08120
Share price
0.00%
Change (1 day)
-95.08%
Change (1 year)
Categories
Earnings for Clovis Oncology (CLVS)
Earnings in 2022 (TTM): -$0.22 B
According to Clovis Oncology's latest financial reports the company's current earnings (TTM) are -$0.22 B. In 2021 the company made an earning of -$0.24 B an increase over its 2020 earnings that were of -$0.35 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Clovis Oncology from 2010 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2022 (TTM) | -$0.22 B | -6.8% |
| 2021 | -$0.24 B | -32.64% |
| 2020 | -$0.35 B | -9.06% |
| 2019 | -$0.39 B | 7.49% |
| 2018 | -$0.36 B | 4.42% |
| 2017 | -$0.34 B | -8.83% |
| 2016 | -$0.38 B | -0.4% |
| 2015 | -$0.38 B | 140.82% |
| 2014 | -$0.16 B | 86.64% |
| 2013 | -$83.12 M | 19.53% |
| 2012 | -$69.54 M | |
| 2010 | -$26.63 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $16.97 B | -7,906.66% | 🇺🇸 USA |
 Pfizer PFE | $3.26 B | -1,602.73% | 🇺🇸 USA |
 AbbVie ABBV | $6.25 B | -2,974.83% | 🇺🇸 USA |
 Eli Lilly LLY | $6.55 B | -3,114.94% | 🇺🇸 USA |
 AstraZeneca AZN | $9.08 B | -4,277.02% | 🇬🇧 UK |
 BioMarin Pharmaceutical BMRN | $0.18 B | -186.73% | 🇺🇸 USA |